The IBM Paradox: A Record High, a Brutal Selloff, and the July 22 Verdict
20.06.2026 - 16:06:03 | boerse-global.de
The ride has been nothing short of spectacular. On June 1, IBM shares hit a 52-week high of €292.85, fueled by quantum-computing announcements and a bullish Barclays initiation — “Overweight” with a $350 target — that pushed the stock to a one-week gain of 17.3%, the biggest since April 2001. But that euphoria evaporated almost as quickly as it came. By the close of the week ending June 20, the stock had slumped to €217.00, shedding 7.78% in five days alone. From the peak, the decline now stands at roughly 26%, a whipsaw that has left investors questioning how much of IBM’s AI story is real — and how much is wishful thinking.
The immediate trigger came from an unlikely source: rival Accenture. Mid-June, the consultancy trimmed the upper end of its fiscal 2026 revenue forecast to $72.5 billion from $73.2 billion, a seemingly modest cut that sent Accenture’s own shares tumbling more than 17% at the open. Because Accenture is viewed as a bellwether for IT services demand, the whole sector caught the contagion. IBM’s consulting unit, which grew a bare 1% in the first quarter, was especially exposed. The market read the Accenture warning as a vote of no confidence in the entire consulting-dependent AI market.
Compounding that blow, IBM’s own research arm poured gasoline on the fire. On June 17, the IBM Institute for Business Value published a study showing that 91% of corporate leaders do not fully understand their AI dependencies, while 71% struggle with vendor lock-in. Analysts quickly warned that such confusion could push large clients to delay big AI deployments, putting the near-term monetization of IBM’s watsonx platform at risk. The irony was not lost: IBM had positioned itself as the guide through the AI wilderness, and its own data suggested the clients were not ready to follow.
Should investors sell immediately? Or is it worth buying IBM?
Yet for all the hand-wringing over consulting, IBM’s software engine is humming. The software segment delivered its strongest first quarter in a decade, with revenue climbing 6% to $7.1 billion and free cash flow rising at a double-digit clip. Management has targeted more than 10% software growth for the full year 2026, a pace that could offset the consulting headwinds. Partnerships are reinforcing that push: a deeper collaboration with ServiceNow, announced in the same period, aims to modernize legacy systems and automate IT processes, with joint solutions available in the second half of 2026. And a separate tie-up with Google Cloud to scale AI deployments combines IBM’s industry expertise with Gemini Enterprise Agent Platform.
These moves explain why Barclays still sees a path to €350 on the stock. The average analyst price target of €253.68 implies upside of nearly 17% from current levels. First-quarter results already showed a beat: earnings per share of $1.91 against consensus of $1.81. For the full year, IBM reaffirmed revenue growth above 5% in constant currency.
Technically, the stock is clinging to a thin lifeline. At €217.00, it sits just 0.72% above its 50-day moving average of €215.44, a short-term support that has held for now. But the 200-day average of €235.59 is nearly 8% above the current price, confirming a bearish intermediate trend. The RSI has fallen to 42.5, nearing oversold territory, while the 30-day annualized volatility of 67.66% reflects the extreme swings of the past month.
All eyes now turn to July 22, when IBM reports second-quarter earnings. Analysts expect revenue of roughly $17.8 billion and EPS of about $2.98. The critical question is whether IBM can convert its AI order backlog — where generative AI now accounts for around 30% of consulting bookings — into recognized revenue. A strong update on AI delivery could halt the current downtrend and prove that the software-driven transformation is more than a consolation prize. Until then, the stock remains hostage to sector sentiment and the lingering shadow of Accenture’s cautious outlook.
Ad
IBM Stock: New Analysis - 20 June
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
